At the forefront of therapies for rare and orphan diseasesTM
HOME CONTACT US         
Share
about us| programs| science & technology | patient advocacy | clinical studies | investors | collaborations | news & events
 
Investors
 



Home >> Investor Relations >> Corporate Governance >> Insider Transactions

Insider Transactions

Date Name Title Type Shares Traded Price Range Sorted Descending
Feb 5, 2008 topper james n Director Buy 32,864 10.32 - 10.50
Feb 4, 2008 topper james n Director Buy 33,823 10.32 - 10.50
Jun 4, 2008 crowley john f Officer Automatic Sell 5,000 10.29 - 10.50
Jul 16, 2009 crowley john f Officer Automatic Sell 3,500 10.29
Jul 14, 2009 crowley john f Officer Automatic Sell 4,748 10.28
Nov 3, 2008 crowley john f Officer Automatic Sell 10,000 10.27 - 10.29
May 2, 2008 crowley john f Officer Automatic Sell 4,795 10.26 - 10.72
Jul 9, 2009 crowley john f Officer Automatic Sell 1,652 10.24
Nov 3, 2008 bloch stephen m Director Automatic Sell 3,000 10.24
Feb 1, 2008 dentzer james e Officer Disposition (Non Open Market) 220 10.24
Jan 31, 2008 fhm iv lp Beneficial Owner (10% or more) Buy 8,800 10.21 - 10.50
Jan 31, 2008 topper james n Director Buy 8,800 10.21 - 10.50
Jun 2, 2008 dentzer james e Officer Disposition (Non Open Market) 220 10.20
Mar 10, 2008 fhm iv lp Beneficial Owner (10% or more) Buy 4,740 10.19 - 10.50
Mar 10, 2008 topper james n Director Buy 4,740 10.19 - 10.50
Feb 5, 2008 fhm iv lp Beneficial Owner (10% or more) Buy 35,536 10.16 - 10.31
Feb 5, 2008 topper james n Director Buy 35,536 10.16 - 10.31
Jan 2, 2008 crowley john f Officer Automatic Sell 9,600 10.13 - 10.67
Jun 2, 2008 crowley john f Officer Automatic Sell 1,300 10.12 - 10.29
Feb 13, 2008 fhm iv lp Beneficial Owner (10% or more) Buy 6,200 10.10 - 10.43
Showing 161-180 of 392 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Amicus Therapeutics, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.


Copyright © 2012 Amicus Therapeutics, Inc. All rights reserved.   Terms of Use | Privacy Policy